share_log
Moomoo 24/7 ·  Apr 23 07:33
Tharimmune Inc: Announces Option Agreement for Key Technologies for Generating Her2/Her3 Antibody Drug Conjugates (Adcs)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment